-
Johnson & Johnson (JNJ $179.29)
- $179.29 P/E (TTM): 19.14X Cap: $431.79B
- View JNJ Profile
- View Questions on JNJ
Detailed Quote
Questions on this company?
Become a Member
Company Profile
{tplLang.businessdescription | toLang tLang}
{ profileData.description }
{tplLang.details | toLang tLang}
{tplLang.ceo | toLang tLang}
{profileData.profile.details.ceo}
{tplLang.employees | toLang tLang}
{profileData.profile.details.employees | numeraljs '0,0'}
{tplLang.issuetype | toLang tLang}
{profileData.profile.details.issuetype | asIssueType}
{tplLang.industryclassifications | toLang tLang}
{tplLang.sector | toLang tLang}
{profileData.profile.classification.sector}
{tplLang.industry | toLang tLang}
{profileData.profile.classification.industry}
{tplLang.toolname| toLang tLang}
There is no {tplLang.toolname| toLang tLang} currently available for
{data.symbolstring}.
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
-
Amgen Inc. (AMGN $293.72)
- $293.72 P/E (TTM): 24.16X Cap: $158.12B
- View AMGN Profile
- View Questions on AMGN
-
Gilead Sciences Inc. (GILD $114.77)
- $114.77 P/E (TTM): 24.4X Cap: $142.40B
- View GILD Profile
- View Questions on GILD
-
AbbVie Inc. (ABBV $210.60)
- $210.60 P/E (TTM): 89.53X Cap: $372.03B
- View ABBV Profile
- View Questions on ABBV
-
Abbott Laboratories (ABT $132.59)
- $132.59 P/E (TTM): 16.56X Cap: $230.76B
- View ABT Profile
- View Questions on ABT
-
The Cigna Group (CI $304.35)
- $304.35 P/E (TTM): 16.54X Cap: $81.23B
- View CI Profile
- View Questions on CI
-
Johnson & Johnson (JNJ $179.29)
- $179.29 P/E (TTM): 19.14X Cap: $431.79B
- View JNJ Profile
- View Questions on JNJ
-
Medtronic plc. (MDT $92.71)
- $92.71 P/E (TTM): 25.24X Cap: $118.78B
- View MDT Profile
- View Questions on MDT
-
Savaria Corporation (SIS $21.15)
- $21.15 P/E (TTM): 27.04X Cap: $1.51B
- View SIS Profile
- View Questions on SIS
- View Reports on SIS
Q: I am mostly content with my health care stocks with the exception of MDT. It has been essentially flat since about 2016 except for the dividend. It did peak around 2022 but has fallen down to previous levels.
What do you think of the longer term for MDT?
Would you make any other changes for slow but reliable growth and higher end of dividends.
As always, thank you for the great service.
What do you think of the longer term for MDT?
Would you make any other changes for slow but reliable growth and higher end of dividends.
As always, thank you for the great service.
-
Chevron Corporation (CVX $158.18)
- $158.18 P/E (TTM): 20.02X Cap: $273.33B
- View CVX Profile
- View Questions on CVX
-
Johnson & Johnson (JNJ $179.29)
- $179.29 P/E (TTM): 19.14X Cap: $431.79B
- View JNJ Profile
- View Questions on JNJ
-
Lockheed Martin Corporation (LMT $446.20)
- $446.20 P/E (TTM): 25.11X Cap: $104.17B
- View LMT Profile
- View Questions on LMT
-
Merck & Company Inc. (MRK $87.37)
- $87.37 P/E (TTM): 12.54X Cap: $218.23B
- View MRK Profile
- View Questions on MRK
-
PepsiCo Inc. (PEP $149.64)
- $149.64 P/E (TTM): 27.14X Cap: $204.86B
- View PEP Profile
- View Questions on PEP
-
AT&T Inc. (T $28.77)
- $28.77 P/E (TTM): 16.73X Cap: $205.71B
- View T Profile
- View Questions on T
-
Verizon Communications Inc. (VZ $44.44)
- $44.44 P/E (TTM): 10.5X Cap: $187.37B
- View VZ Profile
- View Questions on VZ
Q: Good Morning,
I am a retired income investor who recently received a small $40k USD inheritance.
I would like to purchase US dividend paying equities (for geographic exposure) but am concerned about the withholding tax.
Is there any vehicle available to avoid or lessen the tax? I have no room in my registered account.
What are you highest conviction US stocks with plus 4% yield and some growth potential.?
Thanks Dave
I am a retired income investor who recently received a small $40k USD inheritance.
I would like to purchase US dividend paying equities (for geographic exposure) but am concerned about the withholding tax.
Is there any vehicle available to avoid or lessen the tax? I have no room in my registered account.
What are you highest conviction US stocks with plus 4% yield and some growth potential.?
Thanks Dave
-
Gilead Sciences Inc. (GILD $114.77)
- $114.77 P/E (TTM): 24.4X Cap: $142.40B
- View GILD Profile
- View Questions on GILD
-
Intuitive Surgical Inc. (ISRG $476.16)
- $476.16 P/E (TTM): 65.44X Cap: $170.69B
- View ISRG Profile
- View Questions on ISRG
-
AbbVie Inc. (ABBV $210.60)
- $210.60 P/E (TTM): 89.53X Cap: $372.03B
- View ABBV Profile
- View Questions on ABBV
-
Johnson & Johnson (JNJ $179.29)
- $179.29 P/E (TTM): 19.14X Cap: $431.79B
- View JNJ Profile
- View Questions on JNJ
-
Eli Lilly and Company (LLY $711.68)
- $711.68 P/E (TTM): 57.76X Cap: $673.57B
- View LLY Profile
- View Questions on LLY
-
Medtronic plc. (MDT $92.71)
- $92.71 P/E (TTM): 25.24X Cap: $118.78B
- View MDT Profile
- View Questions on MDT
-
Stryker Corporation (SYK $394.22)
- $394.22 P/E (TTM): 50.97X Cap: $150.71B
- View SYK Profile
- View Questions on SYK
-
Thermo Fisher Scientific Inc (TMO $499.99)
- $499.99 P/E (TTM): 27.98X Cap: $188.80B
- View TMO Profile
- View Questions on TMO
-
Health Care Select Sector SPDR (XLV $138.17)
- $138.17 P/E (TTM): 83.67X Cap: $33.42B
- View XLV Profile
- View Questions on XLV
-
iShares U.S. Medical Devices ETF (IHI $62.87)
- $62.87 P/E (TTM): 164.7X Cap: $4.41B
- View IHI Profile
- View Questions on IHI
-
Sabra Health Care REIT Inc. (SBRA $19.55)
- $19.55 P/E (TTM): 32.7X Cap: $4.68B
- View SBRA Profile
- View Questions on SBRA
-
Healthcare Realty Trust Incorporated (HR $16.97)
- $16.97 Cap: $5.96B
- View HR Profile
- View Questions on HR
-
iShares U.S. Pharmaceuticals ETF (IHE $70.99)
- $70.99 P/E (TTM): 63.66X Cap: $582M
- View IHE Profile
- View Questions on IHE
-
Catalyst Pharmaceuticals Inc. (CPRX $21.08)
- $21.08 P/E (TTM): 12.46X Cap: $2.58B
- View CPRX Profile
- View Questions on CPRX
Q: There was an article in the Globe and Mail today by David Rosenberg about the aging population and he suggested health care related investments such as health care REITS, pharma, devices, and services. What do you think of this idea and can you give me a few recommendations in canada and the US for each of the 4 categories (health reits, pharma, devices, sefrvices)? A mix of ETFS and individual stocks would be great.
Insiders
Share Information
SEC Filings
News and Media